20 cyclists, 3 days, 300 miles, 13,000 feet of climbing, to improve the lives of people with cancer.

Follow our journey through our Strava and Instagram accounts.

The number of people living with cancer in the UK will double from two million today to at least four million by 2030.

Currently around 22,718 people are diagnosed with either bladder or kidney cancer in the UK every year and around 47,700 are diagnosed with prostate cancer (that's 1 in 8 men).

Guys Cancer , Guy's and St Thomas'

The award-winning urology centre is one of the UK's biggest and most productive cancer centres linking laboratory research with cancer care.

The £100,000 raised from this ride will fund two clinical research fellows based at Guys Cancer .

Research fellows are able to bridge the gap between clinical medicine and basic science research. They can guide basic science research by providing insight into what will be directly relevant to patient care and can also facilitate the rapid introduction of the latest research into clinical medicine.

You can read more about the areas of work the two research fellows will be working on:

1. Tumour immunology fellow

Immunotherapy is a promising new treatment for many cancer types and the first funded Fellow will focus their efforts in extending the reach of this treatment to more people. In the Urology field it is effective for kidney, bladder and prostate cancer. Not all patients respond to these treatments so work needs to be done to:

1. Find ways to predict who will respond, to save putting patients on treatments that won't help them. 2. Find new immunotherapy treatments for the patients who don't respond to current therapies. 3. Enhance immunotherapy responses whilst milting side effects.

This will improve patient quality of life, as well as extend life expectancy for patients with incurable diseases. A future goal would be to improve cure rates by using immunotherapy in combination with surgery / radiotherapy

2. Urology fellow

The second fellow will lead a project looking at whether directing chemotherapy to the bladder can reduce the number of patients developing bladder cancer after receiving successful treatment for a similar cancer in the kidney.

As soon as positive research findings emerge, our healthcare staff can put these new methods into practice, to ensure patients benefit from the new learning straight away.